Literature DB >> 17666458

Relationship of liver enzymes to insulin sensitivity and intra-abdominal fat.

Tara M Wallace1, Kristina M Utzschneider, Jenny Tong, Darcy B Carr, Sakeneh Zraika, Daniel D Bankson, Robert H Knopp, Steven E Kahn.   

Abstract

OBJECTIVE: The purpose of this study was to determine the relationship between plasma liver enzyme concentrations, insulin sensitivity, and intra-abdominal fat (IAF) distribution. RESEARCH DESIGN AND METHODS: Plasma gamma-glutamyl transferase (GGT), aspartate transaminase (AST), alanine transaminase (ALT) levels, insulin sensitivity (insulin sensitivity index [S(I)]), IAF area, and subcutaneous fat (SCF) area were measured in 177 nondiabetic subjects (75 men and 102 women, aged 31-75 years) with no history of liver disease. On the basis of BMI (< or > or = 27.5 kg/m2) and S(I) (< or > or = 7.0 x 10(-5) min/pmol) subjects were divided into lean insulin sensitive (LIS, n = 53), lean insulin resistant (LIR, n = 60), and obese insulin resistant (OIR, n = 56) groups.
RESULTS: Levels of all three liver enzymes were higher in men than in women (P < 0.0001 for each). In men, GGT levels were higher in insulin-resistant than in insulin-sensitive subjects (P < 0.01). In women, GGT levels were higher in the OIR than in the LIS group (P < 0.01) but no different in the LIR group. There was no difference in ALT and AST levels among the LIS, LIR, and OIR groups. GGT was associated with S(I) (r = -0.26, P < 0.0001), IAF area (r = 0.22, P < 0.01), waist-to-hip ratio (WHR) (r = 0.25, P = 0.001), BMI (r = 0.17, P < 0.05), and SCF area (r = 0.16, P < 0.05) after adjustments for age and sex. In men, only S(I) (r = -0.29, P < 0.05) remained independently correlated with GGT in multiple regression analysis. In women, IAF area (r = 0.29, P < 0.01) and WHR (r = 0.29, P < 0.01) were independently associated with GGT, but S(I) was not.
CONCLUSIONS: In nondiabetic men GGT but not AST or ALT levels, are inversely related to insulin sensitivity independent of IAF area. However in women, GGT is related to measures of central body fat rather than to insulin sensitivity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17666458     DOI: 10.2337/dc06-1758

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  20 in total

1.  Plasma sterol evidence for decreased absorption and increased synthesis of cholesterol in insulin resistance and obesity.

Authors:  Pathmaja Paramsothy; Robert H Knopp; Steven E Kahn; Barbara M Retzlaff; Brian Fish; Lina Ma; Richard E Ostlund
Journal:  Am J Clin Nutr       Date:  2011-09-21       Impact factor: 7.045

2.  Intragastric balloon treatment for obesity: results of a large single center prospective study.

Authors:  Davor Stimac; Sanja Klobučar Majanović; Tamara Turk; Borivoj Kezele; Vanja Licul; Zeljka Crnčević Orlić
Journal:  Obes Surg       Date:  2011-05       Impact factor: 4.129

3.  Risk factors for incident type 2 diabetes in individuals with a BMI of <27 kg/m2: the role of gamma-glutamyltransferase. Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

Authors:  A Gautier; B Balkau; C Lange; J Tichet; F Bonnet
Journal:  Diabetologia       Date:  2009-11-20       Impact factor: 10.122

Review 4.  Effect of Intragastric Balloons on Liver Enzymes: A Systematic Review and Meta-Analysis.

Authors:  Violeta B Popov; Christopher C Thompson; Nitin Kumar; Maria M Ciarleglio; Yanhong Deng; Loren Laine
Journal:  Dig Dis Sci       Date:  2016-05-20       Impact factor: 3.199

5.  Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients.

Authors:  Giorgio Ricci; Gianluca Bersani; Angelo Rossi; Flavia Pigò; Giovanni De Fabritiis; Vittorio Alvisi
Journal:  Obes Surg       Date:  2008-03-28       Impact factor: 4.129

6.  Circulating alanine transaminase (ALT) and γ-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus Metabolism Study.

Authors:  Xiaowen Liu; Ole-Petter R Hamnvik; John P Chamberland; Michael Petrou; Huizhi Gong; Costas A Christophi; David C Christiani; Stefanos N Kales; Christos S Mantzoros
Journal:  Metabolism       Date:  2014-03-15       Impact factor: 8.694

7.  Serum transaminases concentrations in obese children and adolescents.

Authors:  E M González-Gil; G Bueno-Lozano; O Bueno-Lozano; L A Moreno; L Cuadrón-Andres; P Huerta-Blas; J M Garagorri; M Bueno
Journal:  J Physiol Biochem       Date:  2009-03       Impact factor: 4.158

8.  Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women.

Authors:  Fabrice Bonnet; Pierre-Henri Ducluzeau; Amalia Gastaldelli; Martine Laville; Christian H Anderwald; Thomas Konrad; Andrea Mari; Beverley Balkau
Journal:  Diabetes       Date:  2011-04-26       Impact factor: 9.461

9.  Adherence to the Mediterranean diet moderates the association of aminotransferases with the prevalence of the metabolic syndrome; the ATTICA study.

Authors:  Natalia Tzima; Christos Pitsavos; Demosthenes B Panagiotakos; Christina Chrysohoou; Evangelos Polychronopoulos; John Skoumas; Christodoulos Stefanadis
Journal:  Nutr Metab (Lond)       Date:  2009-07-30       Impact factor: 4.169

10.  Effect of 2 years of calorie restriction on liver biomarkers: results from the CALERIE phase 2 randomized controlled trial.

Authors:  James L Dorling; Eric Ravussin; Leanne M Redman; Manju Bhapkar; Kim M Huffman; Susan B Racette; Sai K Das; John W Apolzan; William E Kraus; Christoph Höchsmann; Corby K Martin
Journal:  Eur J Nutr       Date:  2020-08-14       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.